Percutaneous closure of symptomatic ventricular septal defects in children can be achieved with off-label use of an occluder device. A research letter published online November 7, 2012, ahead of print ...

In children with perimembranous ventricular septal defects (VSDs), closure with a catheter-delivered occluder device is safe, providing midterm outcomes similar to those of open-heart surgery, ...

The Structural Heart Occlusion Devices market presents opportunities in offering minimally invasive solutions for congenital heart defects, enhancing recovery. Insights on market trends, competitive ...

Chicago, IL - A nonrandomized trial of a new ventricular septal occluder designed specifically for the closure of defects that occur post-MI suggests that while mortality is still high following the ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore" report has been added to Research and Markets' offering. VSDs are defects in the ...

After bicuspid aortic valve, ventricular septal defects (VSDs) are the most common congenital heart abnormalities. Of all congenital defects, around 20% are solitary lesions and another 10% are ...

A team of doctors of government run Advance Cardiac Institute (ACI) saved the life of a 15-year-old girl by closing her heart’s hole also known as Ventricular Septal Defect (VSD) by using a special ...

Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...

The "US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore" report has been added to Research and Markets' offering. VSDs are defects in the ventricular septum, the wall ...